> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance.md).

# Treatment Resistance

- [Treatment Resistance Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance-overview.md): Overview of treatment-resistance, progression-pattern, and cross-cancer treatment-escape topics
- [Treatment Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance.md): Cross-cancer resistance topics, progression patterns, and treatment-escape questions
- [Treatment Resistance Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/treatment-resistance-overview.md): Overview of treatment-resistance topics that cut across cancer types, regimens, and biomarkers
- [Drug Metabolism & Supplement Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/drug-metabolism-and-supplement-interactions.md): Central landing page for pharmacogenomics, enzyme pathways, transporter logic, and supplement-interaction questions across oncology treatment settings
- [Drug Metabolism & Supplement Interactions Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/drug-metabolism-and-supplement-interactions/drug-metabolism-and-supplement-interactions-overview.md): How to organise shared CYP, transporter, inducer, inhibitor, and regimen-specific supplement interaction topics across the site
- [Dormant Cancer Cells](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells.md)
- [Dormant Cancer Cells](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-1.md)
- [Dormant Cancer Cells](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2.md): Cross-cancer guide to dormancy, residual disease, reactivation risk, and treatment strategy questions
- [Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/overview.md): Why dormant cancer cells matter, how the section is organised, and what questions it helps answer
- [What Dormant Cancer Cells Are](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/what-dormant-cancer-cells-are.md): Plain-language guide to dormant and slow-cycling cancer cells, where they hide, and why they matter
- [Beyond Kill It All](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/beyond-kill-it-all.md): Why aggressive treatment is not always the smartest answer for tiny, slow-growing, or suspected dormant disease
- [Inflammation, Stress and Dormancy Escape](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/inflammation-stress-and-dormancy-escape.md): How inflammation, surgery, infection, and stress signalling can help dormant cancer cells reactivate
- [Treatment Strategies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/treatment-strategies.md): Four main ways to think about residual disease: keep dormant, wake and kill, target cells while dormant, or clear therapy-induced senescent survivors
- [Dormancy-Focused Agents and Adjuncts](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/dormancy-focused-agents-and-adjuncts.md): Examples of drugs, repurposed agents, and compounds discussed in relation to dormant or slow-cycling cancer cells
- [Questions for Your Oncology Team](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/questions-for-your-oncology-team.md): Practical questions that help bring dormancy biology into treatment discussions
- [Dormancy Glossary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/dormancy-glossary.md): Quick definitions for the main terms used across the dormancy pages
- [Autophagy — Cancer's Escape Route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route.md): Hub last updated June 27th 2026 for autophagy-targeted cancer strategy, host protection, and emerging treatments and combination logic
- [The Early Window — Part One](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/the-early-window-part-one.md): Why early autophagy inhibition matters across dormant and treatment-stressed cancer states, including CDK4/6 biology, mebendazole synergy, and the senescence escape problem
- [The Multi-Target Strategy — Part Two](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/the-multi-target-strategy-part-two.md): How the autophagy strategy is designed to layer HCQ, AKBA, metabolic pressure, and host support across multiple cancer survival pathways
- [Protecting the Host — if HCQ is in the Protocol](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/protecting-the-host-if-hcq-is-in-the-protocol.md): How to think about HCQ accumulation, mitochondrial protection, monitoring, diet support, and senolytic follow-up in the autophagy strategy
- [Open Clinical Trial — COAST in Advanced Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/open-clinical-trial-coast-in-advanced-prostate-cancer.md): Evidence-based overview of the COAST autophagy trial in advanced solid tumours and relapsed prostate cancer, including eligibility, dose design, and why the study matters
- [Senescence — The Second Escape Route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/senescence-the-second-escape-route.md): Hub for therapy-induced senescence, SASP biology, senolytic strategy, and safety questions in treatment-resistant cancer care


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
